Fusion Antibodies PLC - Belfast-based contract researcher, which provides discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Conditionally raises GBP1.4.
Fusion Antibodies PLC on Tuesday said it has won a follow-on project under a collaborative research and development agreement with an unnamed US-based biotechnology company.
Shares in Fusion.
Fusion Antibodies PLC on Thursday announced the receipt of a research & development tax credit from UK HM Revenue & Customs for work performed on the development of its OptiMAL platform and other.
Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Appoints Stephen Smyth.
Fusion Antibodies PLC on Monday said it has completed its restructuring plans, in hopes of reducing annualised costs by about GBP2.2 million.
Fusion Antibodies is a Belfast-based contract research. -Today at 03:42 am- MarketScreener